HBIO Stock Summary and Trading Ideas (Harvard Bioscience | NASDAQ:HBIO)

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

What symbol and exchange does Harvard Bioscience shares trade?

Harvard Bioscience trades on the NASDAQ stock market under the symbol HBIO.

What is Harvard Bioscience stock price doing today?

As of December 23, 2025, HBIO stock price declined to $0.71 with 213,007 million shares trading.

What is Harvard Bioscience's Beta?

HBIO has a beta of 2.66, meaning it tends to be more sensitive to market movements. HBIO has a correlation of 0.22 to the broad based SPY ETF.

How much is Harvard Bioscience worth?

HBIO has a market cap of $31.65 million. This is considered a Sub-Micro Cap stock.

How much money does Harvard Bioscience make?

Last quarter Harvard Bioscience reported $21 million in Revenue and $.00 earnings per share. This beat revenue expectation by $591,000 and missed earnings estimates by -$.01.

What is the highest and lowest price Harvard Bioscience traded in the last 3 year period?

In the last 3 years, HBIO traded as high as $6.29 and as low as $.28.

What are the top ETFs holding Harvard Bioscience?

The top ETF exchange traded funds that HBIO belongs to (by Net Assets): VTI, VXF, DFAC, MSSM, DXUV.

Is Harvard Bioscience (HBIO) a good investment?

HBIO has underperformed the market in the last year with a price return of -66.4% while the SPY ETF gained +17.6%. However, in the short term, HBIO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +49.0% vs +3.4% return in SPY. But in the last 2 weeks, HBIO shares have been beat by the market, returning -6.2% compared to an SPY return of +0.9%.

What are the support and resistance levels for Harvard Bioscience (HBIO)?

HBIO support price is $.71 and resistance is $.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HBIO shares will trade within this expected range on the day.